1 year return (CAGR)
28.95%
C4 Therapeutics Inc Exchange (NASDAQ, USD)
CCCC
3.43
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
14.25%
5 year return (CAGR)
-40.81%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
421.98M
Price/Sales
12.04
Ent value
455.51M
Price/Book
1.71
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-26.32%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.40 |
| Daily high | 3.46 |
| Daily low | 3.32 |
| Daily Volume | 1.34M |
| All-time high | 50.50 |
| 1y analyst estimate | 13.33 |
| Beta | 2.94 |
| EPS (TTM) | -0.78 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CCCC | S&P500 | |
| Current price drop from All-time high | -93.21% | -2.63% |
| Highest price drop | -97.82% | -56.47% |
| Date of highest drop | 16 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -72.76% | -10.68% |
| Avg time to new high | 58 days | 12 days |
| Max time to new high | 1249 days | 1805 days |
News
